262 related articles for article (PubMed ID: 22631452)
1. Intravitreal ranibizumab (lucentis) for the treatment of diabetic macular edema: a systematic review and meta-analysis of randomized clinical control trials.
Wang H; Sun X; Liu K; Xu X
Curr Eye Res; 2012 Aug; 37(8):661-70. PubMed ID: 22631452
[TBL] [Abstract][Full Text] [Related]
2. Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema: a meta-analysis of randomized controlled trials.
Chen G; Li W; Tzekov R; Jiang F; Mao S; Tong Y
PLoS One; 2014; 9(12):e115797. PubMed ID: 25541937
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Ranibizumab in Diabetic Macular Edema: Long-Term Outcomes.
Zucchiatti I; Bandello F
Dev Ophthalmol; 2017; 60():63-70. PubMed ID: 28427066
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
Solaiman KA; Diab MM; Abo-Elenin M
Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
[TBL] [Abstract][Full Text] [Related]
5. The Efficacy and Safety of Current Treatments in Diabetic Macular Edema: A Systematic Review and Network Meta-Analysis.
Zhang L; Wang W; Gao Y; Lan J; Xie L
PLoS One; 2016; 11(7):e0159553. PubMed ID: 27434498
[TBL] [Abstract][Full Text] [Related]
6. Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study.
Sepah YJ; Sadiq MA; Boyer D; Callanan D; Gallemore R; Bennett M; Marcus D; Halperin L; Hassan M; Campochiaro PA; Nguyen QD; Do DV;
Ophthalmology; 2016 Dec; 123(12):2581-2587. PubMed ID: 27707550
[TBL] [Abstract][Full Text] [Related]
7. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
Virgili G; Parravano M; Menchini F; Brunetti M
Cochrane Database Syst Rev; 2012 Dec; 12():CD007419. PubMed ID: 23235642
[TBL] [Abstract][Full Text] [Related]
9. Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose).
Do DV; Sepah YJ; Boyer D; Callanan D; Gallemore R; Bennett M; Marcus DM; Halperin L; Sadiq MA; Rajagopalan N; Campochiaro PA; Nguyen QD;
Eye (Lond); 2015 Dec; 29(12):1538-44. PubMed ID: 26228291
[TBL] [Abstract][Full Text] [Related]
10. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Nguyen QD; Brown DM; Marcus DM; Boyer DS; Patel S; Feiner L; Gibson A; Sy J; Rundle AC; Hopkins JJ; Rubio RG; Ehrlich JS;
Ophthalmology; 2012 Apr; 119(4):789-801. PubMed ID: 22330964
[TBL] [Abstract][Full Text] [Related]
11. The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema.
Ishibashi T; Li X; Koh A; Lai TY; Lee FL; Lee WK; Ma Z; Ohji M; Tan N; Cha SB; Shamsazar J; Yau CL;
Ophthalmology; 2015 Jul; 122(7):1402-15. PubMed ID: 25983216
[TBL] [Abstract][Full Text] [Related]
12. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema.
; ; Aiello LP; Beck RW; Bressler NM; Browning DJ; Chalam KV; Davis M; Ferris FL; Glassman AR; Maturi RK; Stockdale CR; Topping TM
Ophthalmology; 2011 Dec; 118(12):e5-14. PubMed ID: 22136692
[TBL] [Abstract][Full Text] [Related]
13. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
[TBL] [Abstract][Full Text] [Related]
14. Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.
Arıkan Yorgun M; Toklu Y; Mutlu M
Int Ophthalmol; 2017 Feb; 37(1):185-196. PubMed ID: 27173834
[TBL] [Abstract][Full Text] [Related]
15. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
[TBL] [Abstract][Full Text] [Related]
16. Ranibizumab: the first vascular endothelial growth factor inhibitor approved for the treatment of diabetic macular edema.
Evoy KE; Abel SR
Ann Pharmacother; 2013 Jun; 47(6):811-8. PubMed ID: 23656749
[TBL] [Abstract][Full Text] [Related]
17. Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials.
Domalpally A; Ip MS; Ehrlich JS
Ophthalmology; 2015 Apr; 122(4):779-86. PubMed ID: 25601535
[TBL] [Abstract][Full Text] [Related]
18. Short-term fluctuation of diabetic macular edema after intravitreal ranibizumab injection.
Querques G; Bux AV; Martinelli D; Iaculli C; Del Curatolo MV; Delle Noci N
Retina; 2009 Oct; 29(9):1274-81. PubMed ID: 19696699
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.
Ozturk BT; Kerimoglu H; Bozkurt B; Okudan S
J Ocul Pharmacol Ther; 2011 Aug; 27(4):373-7. PubMed ID: 21631366
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema: a meta-analysis of randomized controlled trials.
Liu X; Zhou X; Wang Z; Li T; Jiang B
Chin Med J (Engl); 2014; 127(19):3471-6. PubMed ID: 25269916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
